|
|||||
|
|
||||||
Originally published as JCO Early Release 10.1200/JCO.2008.16.3006 on December 29 2008 © 2009 American Society of Clinical Oncology. Behavioral Health Services for Women Who Have Breast CancerFrom the Department of Health Care Policy, Harvard Medical School; and Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA; and Metro Center for Urban Education, Steinhardt School of Education, New York University, New York, NY. Corresponding author: Vanessa Azzone, PhD, Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115; e-mail: azzone{at}hcp.med.harvard.edu. Purpose To explore whether the use of behavioral health services (BHS) among women with breast cancer is influenced by how insurance plans administer these services, we compared utilization of psychotherapy and psychotherapeutic medications among women with breast cancer who received BHS coverage through a carve-out versus integrated arrangement.
Patients and Methods We analyzed insurance claims, enrollment data, and benefit design data from the MarketScan Commercial Claims & Encounters Research Database for the years 1998 to 2002 for women Results Women enrolled in carve-outs were significantly less likely to receive any psychotherapy visits compared with women in integrated arrangements (odds ratio, 0.68; P < .01). Conditional on having received psychotherapy, however, women in carve-out arrangements used more psychotherapy visits than women in integrated arrangements. The use of antianxiety/hypnotic drugs was significantly higher for women in carve-out arrangements versus women in integrated arrangements (36.1% v 32.6%, P < .05). Moreover, women who received psychotherapy were significantly more likely to received antidepressants and antianxiety/hypnotic medications (five and three times more likely, respectively). Conclusion The type of BHS arrangement was associated with the utilization of psychotherapy and psychotherapeutic medications among women with breast cancer. Supported by Grant No. PO1 HS10803-03 (Structuring Markets and Competition in Health Care) from the Agency for Healthcare Research and Quality. Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
Related Article
Related Editorials
This article has been cited by other articles:
|
||||||||||||
|
|||||||||||
|
Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|